Literature DB >> 27622385

PI3K signaling in Leishmania infections.

Peter E Kima1.   

Abstract

PI3K signaling plays a role in the host response to Leishmania infections. At the cellular level PI3K signaling is engaged by the parasite to control several cellular processes, which ensures parasite persistence. At the systemic level, there is evidence that recruitment of regulatory cells into lesions is impaired in the absence of robust PI3K signaling. In this mini-review the more recent studies that investigated the roles of PI3K signaling in Leishmania infections are discussed. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Leishmania; PI3K; Parasite persistence

Mesh:

Substances:

Year:  2016        PMID: 27622385      PMCID: PMC5127740          DOI: 10.1016/j.cellimm.2016.09.004

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

Review 1.  PI3K in lymphocyte development, differentiation and activation.

Authors:  Klaus Okkenhaug; Bart Vanhaesebroeck
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 3.  Signalling through Class I PI3Ks in mammalian cells.

Authors:  P T Hawkins; K E Anderson; K Davidson; L R Stephens
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

Review 4.  Role of class II phosphoinositide 3-kinase in cell signalling.

Authors:  M Falasca; T Maffucci
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

Review 5.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

6.  The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.

Authors:  Dong Liu; Jude E Uzonna
Journal:  J Immunol       Date:  2010-02-12       Impact factor: 5.422

7.  Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells.

Authors:  Masashi Ohtani; Shigenori Nagai; Shuhei Kondo; Shinta Mizuno; Kozue Nakamura; Masanobu Tanabe; Tsutomu Takeuchi; Satoshi Matsuda; Shigeo Koyasu
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113

Review 8.  Discovery and development of small molecule SHIP phosphatase modulators.

Authors:  William G Kerr; John D Chisholm; Dennis R Viernes; Lydia B Choi
Journal:  Med Res Rev       Date:  2013-12-02       Impact factor: 12.944

9.  PI3K-γ inhibitors in the therapeutic intervention of diseases caused by obligate intracellular pathogens.

Authors:  Steve Oghumu; Abhay R Satoskar
Journal:  Commun Integr Biol       Date:  2013-03-01

10.  Deficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovani.

Authors:  Forough Khadem; Zhirong Mou; Dong Liu; Sanjay Varikuti; Abhay Satoskar; Jude E Uzonna
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19
View more
  8 in total

1.  Countervailing, time-dependent effects on host autophagy promotes intracellular survival of Leishmania.

Authors:  Sneha A Thomas; Devki Nandan; Jennifer Kass; Neil E Reiner
Journal:  J Biol Chem       Date:  2017-12-21       Impact factor: 5.157

2.  Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infections.

Authors:  Naixin Zhang; Samiksha Prasad; Charles-Eugene Huyghues Despointes; Jeffrey Young; Peter E Kima
Journal:  Cell Microbiol       Date:  2018-07-31       Impact factor: 3.715

3.  Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host.

Authors:  Sudha Verma; Abhishek Mandal; Md Yousuf Ansari; Ajay Kumar; Kumar Abhishek; Ayan Kumar Ghosh; Ashish Kumar; Vinod Kumar; Sushmita Das; Pradeep Das
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

4.  Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania.

Authors:  Devki Nandan; Naixin Zhang; Yi Yu; Brian Schwartz; Stella Chen; Peter E Kima; Neil E Reiner
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

Review 5.  Glycoconjugates of Gram-negative bacteria and parasitic protozoa - are they similar in orchestrating the innate immune response?

Authors:  Magdalena A Karaś; Anna Turska-Szewczuk; Monika Janczarek; Agnieszka Szuster-Ciesielska
Journal:  Innate Immun       Date:  2019-01       Impact factor: 2.680

6.  Transcriptomic Profile of Canine DH82 Macrophages Infected by Leishmania infantum Promastigotes with Different Virulence Behavior.

Authors:  Alicia Mas; Abel Martínez-Rodrigo; Javier Carrión; José Antonio Orden; Juan F Alzate; Gustavo Domínguez-Bernal; Pilar Horcajo
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

7.  Profilin is involved in G1 to S phase progression and mitotic spindle orientation during Leishmania donovani cell division cycle.

Authors:  Bindu Ambaru; Ganesh Muthu Gangadharan; Hosahalli S Subramanya; Chhitar M Gupta
Journal:  PLoS One       Date:  2022-03-22       Impact factor: 3.240

Review 8.  Transcriptional Studies on Trypanosoma cruzi - Host Cell Interactions: A Complex Puzzle of Variables.

Authors:  María Gabriela Libisch; Natalia Rego; Carlos Robello
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.